Clinical Trials Browser

Active not recruiting × Breast Carcinoma In Situ × 30 days × Clear all

NCT02954874 2026-03-17

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Phase 3 Active not recruiting

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02515110 2026-03-13

Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

Phase NA Active not recruiting

Breast Carcinoma In Situ, Breast Neoplasms

NCT04906200 2026-02-19

YES

Phase NA Active not recruiting

Breast Carcinoma In Situ